CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 425 filers reported holding CRISPR THERAPEUTICS AG in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $205,238 | -80.9% | 3,800 | -75.9% | 0.00% | -100.0% |
Q1 2024 | $1,076,383 | +12.1% | 15,792 | +2.9% | 0.00% | 0.0% |
Q4 2023 | $960,347 | +50.7% | 15,341 | +9.3% | 0.00% | +100.0% |
Q3 2023 | $637,321 | -79.6% | 14,041 | -74.8% | 0.00% | -83.3% |
Q2 2023 | $3,130,535 | +28.1% | 55,763 | +3.2% | 0.01% | +50.0% |
Q1 2023 | $2,444,727 | +19.0% | 54,051 | +6.9% | 0.00% | 0.0% |
Q4 2022 | $2,054,939 | -37.5% | 50,552 | +0.4% | 0.00% | -42.9% |
Q3 2022 | $3,290,000 | +98.6% | 50,343 | +84.6% | 0.01% | +250.0% |
Q2 2022 | $1,657,000 | -3.2% | 27,272 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $1,711,000 | -47.8% | 27,272 | -36.8% | 0.00% | -50.0% |
Q4 2021 | $3,277,000 | -30.4% | 43,137 | +2.6% | 0.00% | -50.0% |
Q3 2021 | $4,707,000 | -56.1% | 42,062 | -36.5% | 0.00% | -55.6% |
Q2 2021 | $10,725,000 | +240.9% | 66,248 | +156.5% | 0.01% | +200.0% |
Q1 2021 | $3,146,000 | -6.9% | 25,827 | +17.1% | 0.00% | 0.0% |
Q4 2020 | $3,379,000 | -3.0% | 22,064 | -73.1% | 0.00% | -40.0% |
Q1 2020 | $3,483,000 | +69.2% | 82,123 | +142.9% | 0.01% | +150.0% |
Q4 2019 | $2,059,000 | +25.9% | 33,807 | -14.8% | 0.00% | 0.0% |
Q3 2019 | $1,636,000 | -42.4% | 39,676 | -34.2% | 0.00% | -33.3% |
Q2 2019 | $2,838,000 | -0.1% | 60,270 | -24.2% | 0.00% | 0.0% |
Q1 2019 | $2,840,000 | +62.1% | 79,516 | +27.5% | 0.00% | +50.0% |
Q4 2018 | $1,752,000 | -34.0% | 62,352 | +4.2% | 0.00% | 0.0% |
Q3 2018 | $2,653,000 | -64.0% | 59,825 | -52.3% | 0.00% | -71.4% |
Q2 2018 | $7,372,000 | -30.7% | 125,457 | -46.1% | 0.01% | -30.0% |
Q1 2018 | $10,639,000 | +95.2% | 232,744 | +0.3% | 0.01% | +150.0% |
Q4 2017 | $5,449,000 | +128.6% | 232,060 | +74.0% | 0.00% | +100.0% |
Q3 2017 | $2,384,000 | – | 133,370 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |